Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 10 April 2017 | By Zachary Brennan
As a way to improve the accuracy and capture of medical device adverse events, the International Medical Device Regulators Forum (IMDRF), a voluntary and global group of device regulators, on Monday published a new final guideline on a harmonized terminology for reporting such events.
"Widespread use of a single, appropriate adverse event terminology and coding system is expected to improve signal detection by adverse event management systems enabling a faster response by both industry and regulatory agencies," IMDRF’s adverse event working group explained.
The 14-page guideline offers IMDRF terms, definitions and alpha-numerical codes to be used for pre- and post-market adverse event reporting for medical devices and in vitro diagnostics.
To ease the use of these terminologies, particularly in databases, and to reduce possible ambiguities, each term in the guideline is uniquely identified by an alpha-numerical code and is further explained by a definition and, in some cases, examples. The terminologies are based on what's currently available and have been reviewed, improved, and as appropriate, either expanded or simplified.
Notably, the guideline says the term "adverse event" in the context of clinical trials (i.e. in the pre-market space) has a more restricted meaning than in the post-market space, and depending on jurisdictions, the term adverse event (in its post-market meaning) and incident can typically be used interchangeably.
However, the guideline notes that "it is important that changes to the AE terminology should be restricted to the absolute necessary, i.e. mainly reserved for adaptation to technical progress (new terms as new devices, designs and materials emerge). Frequent changes to the terminology are not anticipated. Any change for involved parties and end users will require re-programming of existing coding systems at the level of industry, healthcare facilities and regulators alike so needs to be managed with this in mind."
IMDRF terminologies for categorized Adverse Event Reporting (AER): terms, terminology structure and codes
Tags: adverse events for medical devices, IMDRF guideline, GHTF
Regulatory Focus newsletters
All the biggest regulatory news and happenings.